ImPACT Applications:
A Story of Excellence

25 Million Tests

ImPACT Applications, Inc. marks the administration of it’s twentfifth millionth test.

ImPACT for iPad

ImPACT Applications, Inc. releases ImPACT for iPad, increasing the mobility of our test.

ImPACT Applications, Inc. releases ImPACT Version 4 to further assist clinicians with concussion care.

FIFA incorporates ImPACT into their concussion protocol for all players.

20 million tests

ImPACT Applications, Inc. marks the administration of its twenty millionth test.

ImPACT Applications, Inc. offers remote ImPACT post-injury testing via telemedicine to increase accessibility to concussion care worldwide.

Alpine Investors' Riverside Insights Acquires ImPACT Applications, Inc.

ImPACT Applications, Inc. offers the FDA cleared ImPACT Baseline Test to home-based users worldwide.

16 million tests

ImPACT Applications, Inc. marks the administration of its sixteen millionth test.

Premier Health becomes a customer of ImPACT Applications, Inc.

ImPACT Applications, Inc. partners with UPMC, Affidea, and Bon Secours Health System to create the first Nationwide Concussion Network, in Ireland.

14 million tests

ImPACT Applications, Inc. marks the administration of its fourteen millionth test.

ImPACT and ImPACT Pediatric receive regulatory clearance by ANVISA (Brazil). 

ImPACT Applications, Inc. launches ImPACT Pediatric®, the first concussion management tool designed for individuals ages 5-11. ImPACT Pediatric also earns FDA clearance as a Computerized Cognitive Assessment Aid for Concussion.

12 million tests

ImPACT Applications, Inc. marks the administration of its twelve millionth test.

ImPACT becomes the first concussion-specific medical device to receive FDA de novo clearance under Computerized Cognitive Assessment Aid for Concussion, a new category for a device that uses an individual's score(s) on a battery of cognitive tasks to provide an indication of the current level of cognitive function in response to concussion.

The UK-based Football Association, the governing body of football (soccer), partners with ImPACT Applications, Inc. to conduct baseline and post-injury neurocognitive testing using ImPACT and ImPACT Pediatric as part of its larger concussion management protocol. Begins testing of its women’s national teams that month.

Technavio names ImPACT Applications, Inc. among its top seven leading vendors in its report highlighting the cognitive test and assessment market in Europe. 

Formula 1 Racing selects ImPACT as part of its concussion management protocol for all drivers.

ImPACT Applications, Inc. becomes a registered medical device in Australia by receiving Medical Device Establishment License from Australian Therapeutic Goods Administration.

ImPACT Applications, Inc. completes a SOC 2 Type 2 audit in accordance with AICPA Standards for the Security, Availability and Privacy Trust Service Criteria.

ImPACT Applications, Inc. is selected by New York Schools Insurance Reciprocal (NYSIR) to support its Head Injury Prevention Program.

10 million tests

ImPACT Applications, Inc. marks the administration of its ten millionth test.

Canadian Football League signs an agreement with ImPACT Applications, Inc. to provide ImPACT to athletes.

ImPACT Applications, Inc. receives the Bronze Award at the 2015 Edison Awards in testing and evaluation.

ImPACT and ImPACT Pediatric receives Class II medical device license from Health Canada.

ImPACT Applications, Inc. launches ImPACT Workplace, a neurocognitive assessment product for businesses, corporations, and occupational medicine designed to provide employers, healthcare providers, and wellness professionals with an empirically-validated, reliable, and valid procedure for evaluating the neurocognitive status of their employee or patient.

University of St. Augustine for Health Sciences becomes the first institution of higher learning to incorporate ImPACT Trained Athletic Trainer (ITAT) credentialing into the curriculum of its online Master of Health Science in Athletic Training degree program.

ImPACT and ImPACT Pediatric obtains CE Marking and is registered in the EU to comply with European Medical Device Directive.

ImPACT Applications, Inc. receives ISO 13485 certification.

NASCAR begins mandating baseline concussion testing using ImPACT. 

ImPACT Applications, Inc. partners with University Hospitals Case Medical Center to offer a comprehensive concussion management program.

ImPACT Applications, Inc. launches ImPACT Passport, giving trained healthcare professionals the ability to offer the free mobile app to patients and to access test takers’ ImPACT results and reported symptoms.

Lifemark Canada becomes a customer of ImPACT Applications.

Fast Company Magazine names ImPACT Applications, Inc. no. 7 among the world’s 10 most innovative health care companies. 

5 million tests

ImPACT Applications, Inc. marks the administration of its five millionth test.

ImPACT Applications, Inc. introduces the ImPACT Trained Athletic Trainers (ITAT) credentialing program, presenting athletic trainers a new opportunity to become leaders in concussion management. 

ImPACT Applications, Inc. introduces three new concussion management mobile apps: PCSI™ (Post-Concussion Symptom Inventory), Sideline ImPACT®, and Mobile ImPACT Customer Center (MICC).

The Chicago Blackhawks, in conjunction with the Amateur Hockey Association of Illinois (AHAI), Athletico Physical Therapy, and NorthShore University HealthSystem, launch the ‘A Step aHead’ concussion awareness initiative, offering complimentary ImPACT baselines to all AHAI members ages 13-18.

1 million tests

ImPACT Applications, Inc. marks the administration of its one millionth test.

NASCAR becomes a customer of ImPACT Applications, Inc.

ImPACT Applications, Inc. forms a strategic alliance with US Lacrosse to launch a formal concussion management program for lacrosse players using ImPACT for baseline and post-injury testing.

ImPACT Applications, Inc. forms a partnership with Major League Soccer to use ImPACT, marking the company’s first professional sports customer.

Dr. Collins and Dr. Lovell officially incorporate Neurohealth as ImPACT Applications, Inc. with Dr. Lovell as CEO. The first product, ImPACT, is officially released. 

Dr. Lovell and Dr. Collins continue gathering data on the neurocognitive effects of head injuries using the ImPACT technology, working with Dr. Joseph Maroon, co-medical director at UPMC and team neurosurgeon for the Pittsburgh Steelers.  

Dr. Lovell moves to Pittsburgh where he is named founding director of the University of Pittsburgh Medical Center (UPMC) Sports Medicine Concussion Program. 

Dr. Collins joins him to become executive director of the UPMC Sports Medicine Concussion Program. They continue to develop their neurocognitive testing technology separate from their duties at UPMC.  

Dr. Collins joins Dr. Lovell at Neurohealth while continuing his work at the Henry Ford Health System. They conduct research studies at Michigan State University and at several high schools in the Detroit area on their technology which will be the foundation of ImPACT (Immediate Post-Concussion Assessment and Cognitive Test). 

Dr. Lovell joins the Henry Ford Health System in Detroit as a neuropsychologist, where he meets Michael “Micky” Collins, Ph.D. He continues to work on the Neurohealth tests in his free time.

Mark Lovell, Ph.D. develops technology for a computerized neurocognitive test, which becomes the basis for his company, Neurohealth.